KENNETH JAY BARR,JOHN MACLEAN,HONGJUN ZHANG,RICHARD THOMAS BERESIS,NEVILLE ANTHONY,MATTHEW H DANIELS,BLAIR LAPOINTE,NUNZIO SCIAMMETTA
申请号：
PT13829341
公开号：
PT2920149T
申请日:
2013.08.14
申请国别(地区):
PT
年份:
2019
代理人:
摘要：
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
